China Sxt Pharmaceuticals Inc
(SXTC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2018 | 03-2017 | |
| Cash Flows From Operating Activities | ||
| Net Income | 1,180 | 1,180 |
| Depreciation Amortization | 120 | 90 |
| Other Working Capital | 600 | -990 |
| Other Operating Activity | 20 | 10 |
| Operating Cash Flow | $1,920 | $290 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -1,020 | -170 |
| Other Investing Activity | -120 | -10 |
| Investing Cash Flow | $-1,140 | $-180 |
| Cash Flows From Financing Activities | ||
| Other Financing Activity | -310 | -50 |
| Financing Cash Flow | $-310 | $-50 |
| Exchange Rate Effect | 30 | -2 |
| Beginning Cash Position | 60 | 10 |
| End Cash Position | 560 | 60 |
| Net Cash Flow | $490 | $50 |
| Free Cash Flow | ||
| Operating Cash Flow | 1,920 | 290 |
| Free Cash Flow | 1,920 | 290 |